Accelerating benchside to bedside innovation is the ultimate goal for many startup entrepreneurs and VCs specializing in the medical arena. Though the final destination may be clear, the pathway is inevitably convoluted, tortuous and seemingly insurmountable. Herein, we are exploring a streamlined approach to facilitate entrepreneurs with product life cycle management and alleviate potential risks associated with technology, manufacturing and market for VCs prior to investment.